Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Sales (2019 - 2025)

Biodesix (BDSX) has disclosed Return on Sales for 7 consecutive years, with 0.14% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 27.0% year-over-year to 0.14%, compared with a TTM value of 0.4% through Dec 2025, up 20.0%, and an annual FY2025 reading of 0.4%, up 20.0% over the prior year.
  • Return on Sales was 0.14% for Q4 2025 at Biodesix, up from 0.42% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.14% in Q4 2025 and bottomed at 2.38% in Q1 2022.
  • Average Return on Sales over 5 years is 1.03%, with a median of 0.81% recorded in 2023.
  • The sharpest move saw Return on Sales soared 172bps in 2021, then plummeted -217bps in 2022.
  • Year by year, Return on Sales stood at 1.82% in 2021, then rose by 6bps to 1.71% in 2022, then surged by 63bps to 0.63% in 2023, then skyrocketed by 34bps to 0.41% in 2024, then surged by 66bps to 0.14% in 2025.
  • Business Quant data shows Return on Sales for BDSX at 0.14% in Q4 2025, 0.42% in Q3 2025, and 0.58% in Q2 2025.